Navigation Links
Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
Date:12/27/2010

rtant processes that enable cancer growth.  These kinases included Raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET.  

Nexavar is currently approved in 99 countries.  

Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators.

Important Safety Considerations For Patients Taking Nexavar

NEXAVAR in combination with carboplatin and paclitaxel is contraindicated in patients with squamous cell lung cancer. Nexavar may cause fetal harm when administered to a pregnant woman. Women of childbearing potential are advised to avoid becoming pregnant and Female patients should also be advised against breast-feeding while receiving Nexavar.

Cardiac ischemia and/or myocardial infarction may occur. Temporary or permanent discontinuation of Nexavar should be considered in patients who develop cardiac ischemia and/or myocardial infarction.  Gastrointestinal perforation was an uncommon adverse reaction and has been reported in less than 1% of patients taking Nexavar.

Uncommon but serious adverse reactions including keratoacanthomas/squamous cell cancer of the skin and Stevens - Johnson Syndrome have been reported in clinical trials

An increased risk of bleeding may occur following Nexavar administration. If bleeding necessitates medical intervention, consider discontinuation of Nexavar.

Hypertension may occur early in the course of treatment. Monitor blood pressure weekly during the first 6 weeks and periodically thereafter and treat, as required.

Hand-foot skin reaction and rash are common and management may include topical therapies for symptomatic relief.  In cases of any severe or persistent adverse reactions, temporary treatment interruption, dose modification, or permanent discontinuation of Nexavar should be considered.

Temporary interruption of Nexavar therapy is recommended in
'/>"/>

SOURCE Vicus Therapeutics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®
4. PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
5. Silence Therapeutics Provides Year-end Update
6. Angelica Therapeutics Receives a $244,479 Qualified Therapeutic Discovery Project Grant for Its Anti-Cancer Drug
7. Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
8. Osseon® Therapeutics Names Gary Coughlen, CPA as New Chief Financial Officer
9. Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinsons Disease
10. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
11. Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 Research and Markets ... "Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends ... Video communication has been the topic of fascination ... the United States and the Soviet Russia. Earlier ...
(Date:1/23/2015)... 23, 2015  The Partnership to Fight Chronic Disease (PFCD) released a ... leaders and a new study analyzing the impact of increased cost ... nationwide coalition working to educate policy makers and the public on ... was focused on how the Iowa healthcare ...
(Date:1/23/2015)... 23, 2015  MedScope ( www.medscope.org ), the leading provider ... 2015 Connected World magazine Connected World Award ... that can be used anywhere, anytime. The nomination was ... In nominating MedScope, Landon Garner , Director ...
Breaking Medicine Technology:Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2
... Sangart, Inc., a privately held biopharmaceutical company focused ... today announced three new appointments to its executive team. ... the industry,s most influential leaders, while adding to the ... "Sangart believes the quality of our executives should ...
... 15, 2012 /PRNewswire-Asia/ -- China Sky One Medical, Inc. ... CSKI ), a fully integrated pharmaceutical company in ... Mr. Yanqing Liu, the Company,s Chairman, President and Chief ... Following surgery, he is expected to undergo long-term chemotherapy ...
Cached Medicine Technology:Sangart Enhances Leadership Team Bringing Superior Depth of Expertise 2China Sky One Medical Reiterates CEO Sick Leave and Announces Significant Middle Management Resignations 2
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
(Date:1/22/2015)... 22, 2015 Thousand of GranuFlo lawsuits ... recalled its GranuFlo and NaturaLyte dialysis concentrates continue to ... U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP ... Court has remanded a case filed by the state ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining the ... reducing the costs of an auto insurance policy . ... get lower prices for their vehicle insurance policies. The safety a ... policy costs. Because of this, drivers should always carry a ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... 2009 NEW HAVEN, Conn., May 11 VION PHARMACEUTICALS, ... the first quarter of 2009. , , ... per share, for the quarter ended March 31, 2009, compared with ... the same 2008 period. Weighted-average common shares outstanding for the ...
... on the HRS 2009 programST. LOUIS, May 11 ... that the Heart Rhythm 2009 formal program contains 21 ... is either featured or discussed regarding the treatment of ... on the use of Stereotaxis, partnered magnetic irrigated catheter ...
... Mothers Against Drunk Driving (MADD) New York delivered ... showing support for MADD,s Campaign to Eliminate to ... )A key part of MADD,s Campaign to ... the New York State legislature that would expand ...
... Study suggests MRI scans better than questionnaires for evaluations ... seniors who,ve had a stroke fail to report that ... scans rather than patient self-reporting to determine stroke history. ... years and older (average age 80.1) in Manhattan. They ...
... 2009 Iron chelating drugs have been heavily promoted ... form of blood cancer often treated with blood transfusion. ... body, are highly expensive and potentially toxic. A new ... finds that their increased use has been propagated by ...
... neutral, global, multidisciplinary association of professionals involved in the lifecycle ... Career Center--a highly targeted resource for online employment connections. ... ... 11, 2009 -- The Drug Information Association (DIA) , ...
Cached Medicine News:Health News:Vion Pharmaceuticals Reports 2009 First Quarter Results 2Health News:Vion Pharmaceuticals Reports 2009 First Quarter Results 3Health News:Vion Pharmaceuticals Reports 2009 First Quarter Results 4Health News:Vion Pharmaceuticals Reports 2009 First Quarter Results 5Health News:Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2009 2Health News:Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2009 3Health News:Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2009 4Health News:MADD Delivers Nearly 7,000 Petitions to Governor Paterson Urging Ignition Interlocks For All Convicted DWI Offenders 2Health News:Seniors Often Misstate Stroke History 2Health News:Drug Information Association (DIA) Launches New Online Career Center 2Health News:Drug Information Association (DIA) Launches New Online Career Center 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: